Your browser doesn't support javascript.
loading
Campylobacter jejuni capsule types in a Peruvian birth cohort and associations with diarrhoeal disease severity.
Neitenbach, Britney; Poly, Frédéric; Kuroiwa, Janelle; Burga, Rosa; Olortegui, Maribel Paredes; Guerry, Patricia; Kosek, Margaret; Porter, Chad K.
Afiliação
  • Neitenbach B; Enteric Diseases Department,Naval Medical Research Center,Silver Spring, Maryland,USA.
  • Poly F; Enteric Diseases Department,Naval Medical Research Center,Silver Spring, Maryland,USA.
  • Kuroiwa J; Enteric Diseases Department,Naval Medical Research Center,Silver Spring, Maryland,USA.
  • Burga R; Naval Medical Research Unit-6,Lima,Peru.
  • Olortegui MP; Asociacion Benefica PRISMA, Investigaciones Biomedicas,Iquitos,Peru.
  • Guerry P; Enteric Diseases Department,Naval Medical Research Center,Silver Spring, Maryland,USA.
  • Kosek M; Global Disease Epidemiology and Control Department,Johns Hopkins University,Baltimore, Maryland,USA.
  • Porter CK; Enteric Diseases Department,Naval Medical Research Center,Silver Spring, Maryland,USA.
Epidemiol Infect ; 147: e149, 2019 01.
Article em En | MEDLINE | ID: mdl-30868983
ABSTRACT
Campylobacter jejuni is a leading cause of bacterial diarrhoea worldwide. The objective of this study was to examine the association between C. jejuni capsule types and clinical signs and symptoms of diarrhoeal disease in a well-defined birth cohort in Peru. Children were enrolled in the study at birth and followed until 2 years of age as part of the Malnutrition and Enteric Infections birth cohort. Associations between capsule type and clinical outcomes were assessed using the Pearson's χ2 and the Kruskal-Wallis test statistics. A total of 318 C. jejuni samples (30% from symptomatic cases) were included in this analysis. There were 22 different C. jejuni capsule types identified with five accounting for 49.1% of all isolates. The most common capsule types among the total number of isolates were HS4 complex (n = 52, 14.8%), HS5/31 complex (n = 42, 11.9%), HS15 (n = 29, 8.2%), HS2 (n = 26, 7.4%) and HS10 (n = 24, 6.8%). These five capsule types accounted for the majority of C. jejuni infections; however, there was no significant difference in prevalence between symptomatic and asymptomatic infection (all p > 0.05). The majority of isolates (n = 291, 82.7%) were predicted to express a heptose-containing capsule. The predicted presence of methyl phosphoramidate, heptose or deoxyheptose on the capsule was common.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Campylobacter / Campylobacter jejuni / Cápsulas Bacterianas / Diarreia / Genótipo Tipo de estudo: Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Infant / Male / Newborn País/Região como assunto: America do sul / Peru Idioma: En Revista: Epidemiol Infect Assunto da revista: DOENCAS TRANSMISSIVEIS / EPIDEMIOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Campylobacter / Campylobacter jejuni / Cápsulas Bacterianas / Diarreia / Genótipo Tipo de estudo: Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Infant / Male / Newborn País/Região como assunto: America do sul / Peru Idioma: En Revista: Epidemiol Infect Assunto da revista: DOENCAS TRANSMISSIVEIS / EPIDEMIOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos